Domestic institutional brokerages have identified high-conviction buying opportunities across the Indian equity landscape, projecting dramatic share price appreciation between 55 percent and 97 percent over their medium- to long-term investment horizons. Institutional research desks at Choice Institutional Equities and Emkay Global Financial Services have singled out three outperforming counters spanning alternative healthcare, value retail, and premium residential real estate: Jeena Sikho Lifecare, Vishal Mega Mart, and Sobha Limited. Supported by aggressive capacity expansions, surging pre-sales figures, and strong consumer spending patterns across tier-2 and tier-3 growth hubs, these selected equities are positioned as top market picks for investors seeking substantial alpha.

Jeena Sikho Lifecare: Choice Forecasts 97% Surge to ₹1,000 Target

Leading the high-upside forecasts, Choice Institutional Equities issued an aggressive Buy recommendation on alternative healthcare provider Jeena Sikho Lifecare with a target price of ₹1,000 per share. Trading near the ₹508 level, the stock presents an upside potential of 97 percent from its current market valuation. The brokerage's investment thesis highlights the company's rapid expansion across its integrated Ayurveda healthcare delivery network, with management targeting an ambitious bed capacity scale-up to 7,000–10,000 operational beds over the next 3 to 5 years. Accompanied by targeted annual revenue growth of approximately 30 percent, an equal 50:50 revenue split between clinical services and wellness products, and projected EBITDA margins exceeding 40 percent alongside PAT margins of 27–30 percent, Choice models robust revenue, EBITDA, and PAT compound annual growth rates (CAGR) of 33.6 percent, 34.9 percent, and 39.4 percent respectively over the FY26–29E horizon.

Vishal Mega Mart: Emkay Targets ₹170 on Retail Network Scale-Up

In the organized value-retail arena, Emkay Global Financial Services maintained a bullish stance on Vishal Mega Mart, establishing a 12-month target price of ₹170 against its current market price of ₹103.50, translating into a potential upside of 64 percent. Emkay's thesis emphasizes the retailer's private-label market penetration and growing footprint in quick-commerce channels, which are projected to sustain solid double-digit same-store sales growth (SSG). Analysts highlight long-term scope for up to 1,200 large-format department stores nationwide, reinforced by the successful rollout of nimble, small-format retail outlets across emerging semi-urban clusters. Furthermore, the commercial pilot of its youth-focused premium apparel concept "Belong & Co." in Delhi provides additional gross margin headroom, steering Emkay's estimates of an 18 percent top-line expansion and a 27 percent PAT CAGR through FY26–29E.

Sobha Limited: Real Estate Comeback Drives 55% Upside to ₹1,900

Turning to urban infrastructure and property development, Emkay Global placed a confident Buy call on Bengaluru-based luxury real estate developer Sobha Limited, assigning a target price of ₹1,900 per share. With the counter trading near ₹1,227, the recommendation offers an estimated 55 percent upside potential. Following operational consolidations, Sobha staged a sharp financial rebound, booking pre-sales of ₹8,140 crore in FY26—a 30 percent year-on-year surge—followed by first-quarter FY27 pre-sales jumping 76 percent year-on-year to touch ₹3,660 crore. Backed by sustained buyer demand in the Bengaluru metropolitan belt, a robust pipeline of high-margin luxury launches, and accelerating operational cash flows, Emkay projects Sobha’s full-year pre-sales to surpass the ₹10,000 crore benchmark in FY27, with substantial operating margin expansion expected through the second half of the fiscal year.